Miracor touts first-in-man study of catheter for severe heart attacks

Austria's Miracor Medical Systems has safely implanted PISCO, the company's catheter designed to treat patients who have suffered severe heart attacks. The device is implanted after angioplasty and clears blockage to prevent heart failure and facilitate healing. The company is testing the tech on 40 patients in a safety and feasibility study and will soon launch a randomized clinical trial for the device, it said. Report

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.